WO2016183491A1 - Methacrylamide compounds - Google Patents

Methacrylamide compounds Download PDF

Info

Publication number
WO2016183491A1
WO2016183491A1 PCT/US2016/032481 US2016032481W WO2016183491A1 WO 2016183491 A1 WO2016183491 A1 WO 2016183491A1 US 2016032481 W US2016032481 W US 2016032481W WO 2016183491 A1 WO2016183491 A1 WO 2016183491A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
compounds
thiourethane
substituted
monomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2016/032481
Other languages
French (fr)
Inventor
Carmem PFEIFER
Jack FERRACANE
Wilbes MBIYA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health and Science University
Original Assignee
Oregon Health and Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health and Science University filed Critical Oregon Health and Science University
Publication of WO2016183491A1 publication Critical patent/WO2016183491A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/891Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A61K6/893Polyurethanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the field is methacrylamides. More specifically, the field is methacrylamide monomers that can be used, for example, in combination with thiourethane oligomers.
  • (meth)acrylamides may offer greater resistance to hydrolytic/enzymatic attack than
  • Described herein are improved polymers for dental composites based on biocompatible tertiary methacrylamides with the following advantages: First, they allow initiation and fast/effective propagation to high conversions through a free-radical mechanism, while maintaining the feature of on command polymerization initiated by visible light. This is preferable to other curing mechanisms, such as cationic/anionic, which are sensitive to environmental moisture, as well as to filler particle surface charge. In addition, this chemistry ensures that in situ curing with current light activated polymerization schemes already familiar to dentists can be used, enhancing their acceptance by the profession. Second, their glass transition temperature (Tg) is similar to that of methacrylates. Third, (meth)acrylamides have the best hydrolytic stability of the monomers cited.
  • Primary and secondary (meth)acrylamides usually have relatively high melting temperatures, and also are prone to degradation by amylases. This is not the case for the compounds disclosed herein, because the N-H bond typically required in the protease-based hydrolysis is not present. Moreover, ⁇ , ⁇ -dialkyl amide bonds are much bulkier than the amide bonds in proteins and hinder the fit in the catalytic center of a protease for hydrolysis. Finally, a variety of backbone structures can be designed from this platform, to include flexible/stiff extenders and to control the magnitude of secondary intermolecular interactions (i.e. hydrogen bonding and pi-stacking), which in turn control mechanical properties.
  • secondary intermolecular interactions i.e. hydrogen bonding and pi-stacking
  • X is a 5- or 6-membered heterocycloalkyl, wherein n is an integer selected from 0, 1, and 2, and wherein R is selected from alkyl, substituted alkyl, aryl, substituted aryl, or dicycloalkyl. In further examples, R is selected from:
  • compositions further comprising thiourethane oligomers as well as dental composites comprising the compositions.
  • Figure 1 depicts the degree of conversion measured in mid-IR for the indicated methacrylamides as well as TEGDMA. All were formulated with 0.5% by weight CQ, 0.8% by weight EDMAB, and 0.5% by weight DPI-PF6 and polymerized at 800 mW/cm 2 for 10 minutes.
  • Figure 2 depicts the shear storage modulus (G') measured in a parallel plate rheometer for the indicated methacrylamides, PEGDMA and a mixture of BisGMA/UDMA/TEGDMA at 5/3/2. All were formulated with 0.5% by weight CQ, 0.8% by weight EDMAB, and 0.5% by weight DPI-PF6 and polymerized at 800 mW/cm 2 for 10 minutes. DETAILED DESCRIPTION
  • AlkyI a branched or unbranched saturated hydrocarbon group, such as, without limitation, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, tetradecyl, hexadecyl, eicosyl, tetracosyl and the like.
  • a lower alkyl group is a saturated branched or unbranched hydrocarbon having from 1 to 6 carbon atoms (Ci_ 6 alkyl).
  • alkyl also encompasses cycloalkyls.
  • Alkyl also encompasses substituted alkyls which are alkyl groups wherein one or more hydrogen atoms are replaced with a substituent such as, without limitation, alkyl, alkynyl, alkenyl, aryl, halide, nitro, amino, ester, ether, ketone, aldehyde, hydroxyl, carboxyl, cyano, amido, haloalkyl, haloalkoxy, or alkoxy.
  • the term alkyl also encompasses heteroalkyls.
  • a heteroalkyl contains at least one heteroatom such as nitrogen, oxygen, sulfur, or phosphorus replacing one or more of the carbons.
  • Substituted heteroalkyls are also encompassed by the term alkyl.
  • a dicycloalkyl is a branched or unbranched alkyl substituted with two substituted or unsubstituted cycloalkyls.
  • Aryl any carbon-based aromatic group including, but not limited to, benzene, naphthalene, and phenyl.
  • aryl also contemplates substituted aryls in which one or more of the hydrogens is substituted with one or more groups including but not limited to alkyl, alkynyl, alkenyl, aryl, halide, nitro, amino, ester, ether, ketone, aldehyde, hydroxy, carboxylic acid, cyano, amido, haloalkyl, haloalkoxy, or alkoxy.
  • aryl also contemplates
  • heteroaryls in which one or more of the carbons is replaced by a heteroatom.
  • heteroatoms include, but are not limited to, nitrogen, oxygen, sulfur, and phosphorous.
  • Substituted heteroaryls are also encompassed by the term aryl.
  • Cycloalkyl a non-aromatic carbon-based ring composed of at least three carbon atoms.
  • Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. Cycloalkyls also encompass substituted cycloalkyls and
  • heterocycloalkyls where at least one of the carbon atoms is replaced with a heteroatom such as nitrogen, sulfur or phosphorus.
  • a heterocycloalkyl wherein one or more of the carbons is replaced with nitrogen is also termed a cycloalkylamino herein.
  • the term also encompasses substituted heterocycloalkyls.
  • Methacrylamides are well known for their hydrolytic stability and, specifically for tertiary methacrylamides, resistance to protease degradation. Synthetic pathways have been designed to produce novel methacrylamides that can be screened for their mechanical and chemical suitability as dental monomers by flexure testing (ISO4049), polymerization kinetics (FTIR), and enzymatic and hydrolytic resistance by comparison with known controls and established targets. Such new methacrylamide compounds can be further tested for polymerization shrinkage, polymerization stress, depth of cure, water sorption/solubility, demonstration of reduced degradation in water/enzymes in low pH, and adequate resistance to cyclic fatigue, to determine that the disclosed resins have improved properties relative to current methacrylate resins.
  • micro-hybrid composites can be formulated with at least 75% (by weight) silane-treated filler, and tested according to the same scheme as the neat polymers. Subsequently, an intraoral physiologic simulator composed of a biofilm forming/mechanical fatiguing device can be used to study the resistance of the novel composite restoratives placed in defined cavities to surface and tooth-restorative interfacial failure compared to current commercial methacrylate-based composites during six years of clinical simulation.
  • the disclosed methacrylamide monomers can be added to thiourethane oligomers thereby providing the resulting composites with systematically enhanced fracture toughness based on the structure and rigidity of the backbone of the isocyanate or thiol precursor molecules used.
  • the addition of thiourethane oligomers also can also result in less shrinkage of the resin (proportionally to the concentration of oligomer), such as less than 4%.
  • the disclosed methacrylamide monomers can be used in conjunction with an adhesive system in order for it to interact with the tooth.
  • the disclosed tertiary methacrylamide monomers can be used in low-viscosity formulations (by the addition of solvents and hydrophilic, small molecular weight monomers) in conjunction with an etch-and-rinse protocol. Bond strength can be assessed after restoration and after 6 months of storage in physiological conditions. The activity of dentin enzymes can be evaluated through zymography. Results can be compared with those of other methacrylate systems.
  • Scheme 1 is a route to produce more reactive methacrylamides. 3-methylenepiperidin- 2-one is reacted with l,2-di(ll 3 -oxiran-l-yl)ethane in water for 5-24 hours at room temperature to yield compound 3b.
  • Scheme 2 is a synthetic route to produce methacrylamides tested as described herein.
  • Step A of Scheme 2 Methacryloyl chloride (2.1 mol) in dichloromethane (8 mL) was added dropwise to a stirred solution of 4-hydroxypiperidine (2.0 mols) and triethylamine (TEA, 2.1 mols) which was the acid scavenger in dichloromethane (25 mL) at 0°C under an inert atmosphere (Nitrogen gas). After the addition was complete, the reaction mixture was stirred at 0°C for a further 2hrs and 0.05 mols of 4-dimethylaminopyridine (DMAP) a catalyst was added. The reaction was allowed to proceed at room temperature for 22hrs.
  • DMAP 4-dimethylaminopyridine
  • the 2- ethylamino-ethanol monohydrochloride was extracted with 10 % (w/v) sodium hydroxide in water and the organic portion was extracted with dichloromethane (3 x 40 mL) using a separator funnel. The organic portion was dried using sodium sulfate and then evaporated under reduce pressure to give the crude product as yellow oil. The residue was purified by a silica gel column using ethyl acetate: hexane: methanol ratio (8:1:1). The final product, which was a pale yellow liquid (yield 78-86 %) was characterized using 1 H NMR, FT-IR and HRMS.
  • Step B the methacrylamide (2.1 mols) made in step A was mixed with 1.0 mol of diisocyanate (BDI, DESM or HDDI) in 25 mL of tetrahydrofuran (THF) and a drop of the catalyst dibutyl tin dilaurate (DTD) was added.
  • the reaction was heated to 50 °C under reflux while monitoring the disappearance of the isocyanate peak at ⁇ 2270 cm 1 using IR for 18 to 24 hrs.
  • the removal of the solvent using rotary vapor gave a clear viscous liquid (yield ⁇ 96 %) which was characterized using 1 H NMR, FT-IR and HRMS.
  • the compounds described herein can be combined with thiourethane oligomers.
  • isocyanates and thiols can be reacted with one another to form thiourethane networks.
  • Such networks result in improved toughness, a high refractive index, and optical clarity.
  • a Flory-Stockmeyer equation can be used to select starting amounts of isocyanates and thiols to result in pendant isocyanate or pendant thiol groups which can be in turn be functionalized with the
  • a thiol terminated thiourethane oligomer can be produced when an excess of thiol compound is added to an isocyanate compound.
  • 5g of one or thiol compounds can be added to 1.8 g of one or more isocyanate compounds in a two neck round bottom flask at room temperature.
  • the flask can be purged with N 2 gas for one hour.
  • a catalytic amount of triethyl amine is added.
  • the flask is again purged with N 2 gas for 10 minutes and immersed in an ice bath for four hours.
  • a second mid-IR spectrum can be taken at this point.
  • the isocyanate peak at 2270 cm "1 will be reduced (potentially to zero) if the reaction is complete.
  • the resulting mixture is added drop wise to a volume of hexane that is 4x the volume of the mixture. This is allowed to separate at least 4 hours. The supernatant is discarded and the product is resuspended in dry acetone. Solvent is removed with rotary evaporation.
  • an isocyanate-terminated thiourethane oligomer can be produced when an excess of isocyanate compound is added to a thiol compound.
  • 5g of one or more isocyanate compounds can be added to 2 g of one or more thiol compounds in a two neck round bottom flask at room temperature.
  • a mid-IR spectrum can be taken at this point.
  • the flask is purged with N 2 gas for one hour.
  • a catalytic amount of triethyl amine is added.
  • the flask is again purged with N 2 gas for 10 minutes and immersed in an ice bath for four hours.
  • a second mid-IR spectrum can be taken at this point.
  • the thiol peak can be reduced (potentially to zero) if the reaction is complete.
  • the resulting mixture is added drop wise to a volume of hexane that is 4x the volume of the mixture. This is allowed to separate at least 4 hours. The supernatant is discarded and the product is resuspended in dry acetone. Solvent is removed with rotary evaporation.
  • Dental composites comprising the disclosed compounds are also contemplated.
  • Such dental composites can comprise the methacrylate/thiourethane oligomer compositions described.
  • Such dental composites can further comprise tertiary amine, d-camphorquinone, inhibitors, and other compositions, including one or more filler compositions
  • a thiourethane oligomer can comprise at least 10% of the total weight of the dental composite.
  • the methacrylate monomers were were produced in small quantities, not enough to produce the required amount of flexure bars. Therefore, shear modulus was measured using a DHR-1 rheometer (TA Instruments) using a 20 ⁇ gap, at a frequency of 1 Hz and strain of 0.1 %. The rheometer is equipped with a UV-accessory that allows for light access and in situ curing. The light intensity actually reaching the specimen was the same as used for the IR experiments. Total exposure time was 30 min, with data being collected every 1 s. Results for shear modulus at 10 and 30 min are shown in Figure 5.
  • PEGDMA Polyethylene glycol dimethacrylate
  • methacrylamides compared to a dimethacrylate control (PEGDMA) at 10 min. At 30 min, some methacrylamides presented similar or greater G' than the control, adding evidence for the slower polymerization rate and network formation of the current systems.
  • PEGDMA dimethacrylate control

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)

Abstract

New methacrylate compounds are disclosed as well as compositions comprising the methacrylate compounds and thiourethane oligomers. These compositions can be used in, for example, dental composites.

Description

TITLE
METHACRYLAMIDE COMPOUNDS
FIELD
Generally, the field is methacrylamides. More specifically, the field is methacrylamide monomers that can be used, for example, in combination with thiourethane oligomers.
ACKNOWLEDGEMENT OF GOVERNMENT SUPPORT
This invention was made with the support of the United States government under the terms of grant number UOl DE02756, awarded by the National Institutes of Health. The United States government has certain rights to this invention.
BACKGROUND
The service life of dental composite restorations averages 7 years. The main causes for replacement are secondary caries and fracture. Some controlled clinical studies, for mostly conservative composite restorations, show survivals of 10-20 years. But data from cross- sectional and other controlled studies prove that current formulations are not adequately stable. Material degradation over time in the mouth, coupled with variations in microflora and caries risk in certain patients, greatly contributes to reduced service life.
While most of the improvements in composites have come from altering the filler technology, recently new monomers have been developed to decrease polymerization shrinkage and its associated stress. However, most still rely on resin matrices with methacrylate chemistry. The main disadvantage of methacrylates is the relatively low resistance to degradation by hydrolysis and enzymatic attack by esterases, leading to breakdown of the restorative material and the composite/tooth interface. Therefore, there is an urgent need to develop new composites based on more stable compounds, while at the same time maintaining or exceeding the mechanical properties and shrinkage/stress behavior of current commercial materials. Methacrylate monomers have been used as the main constituents in the resin matrix in composite materials for over 50 years. Their relative success derives from excellent aesthetic properties, convenient and fast cure on command, rigidity similar to dentin, and mechanical stability. Despite these aspects, there are significant negative attributes that limit their longevity in the oral cavity, such as high shrinkage and accompanying stress, lower than desirable fracture toughness, relatively low degree of conversion (DC), and high rate of degradation by hydrolysis and enzymatic attack of the resin matrix and the composite/tooth interfacial bond. The goal of this proposal is to develop novel resin systems that will maintain or improve upon the beneficial assets while addressing the shortcomings of methacrylates.
Many available monomers, such as epoxies, vinyl ethers, allyl ethers, maleimides or
(meth)acrylamides, may offer greater resistance to hydrolytic/enzymatic attack than
methacrylates.
SUMMARY
Described herein are improved polymers for dental composites based on biocompatible tertiary methacrylamides with the following advantages: First, they allow initiation and fast/effective propagation to high conversions through a free-radical mechanism, while maintaining the feature of on command polymerization initiated by visible light. This is preferable to other curing mechanisms, such as cationic/anionic, which are sensitive to environmental moisture, as well as to filler particle surface charge. In addition, this chemistry ensures that in situ curing with current light activated polymerization schemes already familiar to dentists can be used, enhancing their acceptance by the profession. Second, their glass transition temperature (Tg) is similar to that of methacrylates. Third, (meth)acrylamides have the best hydrolytic stability of the monomers cited. Primary and secondary (meth)acrylamides usually have relatively high melting temperatures, and also are prone to degradation by amylases. This is not the case for the compounds disclosed herein, because the N-H bond typically required in the protease-based hydrolysis is not present. Moreover, Ν,Ν-dialkyl amide bonds are much bulkier than the amide bonds in proteins and hinder the fit in the catalytic center of a protease for hydrolysis. Finally, a variety of backbone structures can be designed from this platform, to include flexible/stiff extenders and to control the magnitude of secondary intermolecular interactions (i.e. hydrogen bonding and pi-stacking), which in turn control mechanical properties.
Described are com ounds with the structure:
Figure imgf000004_0001
wherein X is a 5- or 6-membered heterocycloalkyl, wherein n is an integer selected from 0, 1, and 2, and wherein R is selected from alkyl, substituted alkyl, aryl, substituted aryl, or dicycloalkyl. In further examples, R is selected from:
Figure imgf000004_0002
Also described are the disclosed compounds in a composition further comprising thiourethane oligomers as well as dental composites comprising the compositions.
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
Figure 1 depicts the degree of conversion measured in mid-IR for the indicated methacrylamides as well as TEGDMA. All were formulated with 0.5% by weight CQ, 0.8% by weight EDMAB, and 0.5% by weight DPI-PF6 and polymerized at 800 mW/cm2 for 10 minutes.
Figure 2 depicts the shear storage modulus (G') measured in a parallel plate rheometer for the indicated methacrylamides, PEGDMA and a mixture of BisGMA/UDMA/TEGDMA at 5/3/2. All were formulated with 0.5% by weight CQ, 0.8% by weight EDMAB, and 0.5% by weight DPI-PF6 and polymerized at 800 mW/cm2 for 10 minutes. DETAILED DESCRIPTION
AlkyI : a branched or unbranched saturated hydrocarbon group, such as, without limitation, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, tetradecyl, hexadecyl, eicosyl, tetracosyl and the like. A lower alkyl group is a saturated branched or unbranched hydrocarbon having from 1 to 6 carbon atoms (Ci_6 alkyl). The term alkyl also encompasses cycloalkyls. Alkyl also encompasses substituted alkyls which are alkyl groups wherein one or more hydrogen atoms are replaced with a substituent such as, without limitation, alkyl, alkynyl, alkenyl, aryl, halide, nitro, amino, ester, ether, ketone, aldehyde, hydroxyl, carboxyl, cyano, amido, haloalkyl, haloalkoxy, or alkoxy. The term alkyl also encompasses heteroalkyls. A heteroalkyl contains at least one heteroatom such as nitrogen, oxygen, sulfur, or phosphorus replacing one or more of the carbons. Substituted heteroalkyls are also encompassed by the term alkyl. A dicycloalkyl is a branched or unbranched alkyl substituted with two substituted or unsubstituted cycloalkyls.
Aryl: any carbon-based aromatic group including, but not limited to, benzene, naphthalene, and phenyl. The term aryl also contemplates substituted aryls in which one or more of the hydrogens is substituted with one or more groups including but not limited to alkyl, alkynyl, alkenyl, aryl, halide, nitro, amino, ester, ether, ketone, aldehyde, hydroxy, carboxylic acid, cyano, amido, haloalkyl, haloalkoxy, or alkoxy. The term aryl also contemplates
heteroaryls in which one or more of the carbons is replaced by a heteroatom. Examples of heteroatoms include, but are not limited to, nitrogen, oxygen, sulfur, and phosphorous.
Substituted heteroaryls are also encompassed by the term aryl.
Cycloalkyl: a non-aromatic carbon-based ring composed of at least three carbon atoms. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. Cycloalkyls also encompass substituted cycloalkyls and
heterocycloalkyls where at least one of the carbon atoms is replaced with a heteroatom such as nitrogen, sulfur or phosphorus. A heterocycloalkyl wherein one or more of the carbons is replaced with nitrogen is also termed a cycloalkylamino herein. The term also encompasses substituted heterocycloalkyls.
Methacrylamides are well known for their hydrolytic stability and, specifically for tertiary methacrylamides, resistance to protease degradation. Synthetic pathways have been designed to produce novel methacrylamides that can be screened for their mechanical and chemical suitability as dental monomers by flexure testing (ISO4049), polymerization kinetics (FTIR), and enzymatic and hydrolytic resistance by comparison with known controls and established targets. Such new methacrylamide compounds can be further tested for polymerization shrinkage, polymerization stress, depth of cure, water sorption/solubility, demonstration of reduced degradation in water/enzymes in low pH, and adequate resistance to cyclic fatigue, to determine that the disclosed resins have improved properties relative to current methacrylate resins.
Using the disclosed methacrylamide monomers, micro-hybrid composites can be formulated with at least 75% (by weight) silane-treated filler, and tested according to the same scheme as the neat polymers. Subsequently, an intraoral physiologic simulator composed of a biofilm forming/mechanical fatiguing device can be used to study the resistance of the novel composite restoratives placed in defined cavities to surface and tooth-restorative interfacial failure compared to current commercial methacrylate-based composites during six years of clinical simulation.
The disclosed methacrylamide monomers can be added to thiourethane oligomers thereby providing the resulting composites with systematically enhanced fracture toughness based on the structure and rigidity of the backbone of the isocyanate or thiol precursor molecules used. The addition of thiourethane oligomers also can also result in less shrinkage of the resin (proportionally to the concentration of oligomer), such as less than 4%.
The disclosed methacrylamide monomers can be used in conjunction with an adhesive system in order for it to interact with the tooth. The disclosed tertiary methacrylamide monomers can be used in low-viscosity formulations (by the addition of solvents and hydrophilic, small molecular weight monomers) in conjunction with an etch-and-rinse protocol. Bond strength can be assessed after restoration and after 6 months of storage in physiological conditions. The activity of dentin enzymes can be evaluated through zymography. Results can be compared with those of other methacrylate systems.
Synthesis:
Scheme 1
Figure imgf000007_0001
Scheme 1 is a route to produce more reactive methacrylamides. 3-methylenepiperidin- 2-one is reacted with l,2-di(ll3-oxiran-l-yl)ethane in water for 5-24 hours at room temperature to yield compound 3b.
Scheme 2 is a synthetic route to produce methacrylamides tested as described herein.
Figure imgf000007_0002
+ OCN,
NCO
HDDI
Figure imgf000008_0001
Figure imgf000008_0002
Figure imgf000008_0003
In Step A of Scheme 2, Methacryloyl chloride (2.1 mol) in dichloromethane (8 mL) was added dropwise to a stirred solution of 4-hydroxypiperidine (2.0 mols) and triethylamine (TEA, 2.1 mols) which was the acid scavenger in dichloromethane (25 mL) at 0°C under an inert atmosphere (Nitrogen gas). After the addition was complete, the reaction mixture was stirred at 0°C for a further 2hrs and 0.05 mols of 4-dimethylaminopyridine (DMAP) a catalyst was added. The reaction was allowed to proceed at room temperature for 22hrs. After that, the 2- ethylamino-ethanol monohydrochloride was extracted with 10 % (w/v) sodium hydroxide in water and the organic portion was extracted with dichloromethane (3 x 40 mL) using a separator funnel. The organic portion was dried using sodium sulfate and then evaporated under reduce pressure to give the crude product as yellow oil. The residue was purified by a silica gel column using ethyl acetate: hexane: methanol ratio (8:1:1). The final product, which was a pale yellow liquid (yield 78-86 %) was characterized using 1H NMR, FT-IR and HRMS. In Step B the methacrylamide (2.1 mols) made in step A was mixed with 1.0 mol of diisocyanate (BDI, DESM or HDDI) in 25 mL of tetrahydrofuran (THF) and a drop of the catalyst dibutyl tin dilaurate (DTD) was added. The reaction was heated to 50 °C under reflux while monitoring the disappearance of the isocyanate peak at ~2270 cm 1 using IR for 18 to 24 hrs. The removal of the solvent using rotary vapor gave a clear viscous liquid (yield < 96 %) which was characterized using 1H NMR, FT-IR and HRMS.
The compounds described herein can be combined with thiourethane oligomers. As described in PCT/US15/21016 (incorporated by reference herein), isocyanates and thiols can be reacted with one another to form thiourethane networks. Such networks result in improved toughness, a high refractive index, and optical clarity. For example, a Flory-Stockmeyer equation can be used to select starting amounts of isocyanates and thiols to result in pendant isocyanate or pendant thiol groups which can be in turn be functionalized with the
methacrylamide compounds described herein.
For example, a thiol terminated thiourethane oligomer can be produced when an excess of thiol compound is added to an isocyanate compound. For example, 5g of one or thiol compounds can be added to 1.8 g of one or more isocyanate compounds in a two neck round bottom flask at room temperature. The flask can be purged with N2 gas for one hour. A catalytic amount of triethyl amine is added. The flask is again purged with N2 gas for 10 minutes and immersed in an ice bath for four hours. A second mid-IR spectrum can be taken at this point. The isocyanate peak at 2270 cm"1 will be reduced (potentially to zero) if the reaction is complete. The resulting mixture is added drop wise to a volume of hexane that is 4x the volume of the mixture. This is allowed to separate at least 4 hours. The supernatant is discarded and the product is resuspended in dry acetone. Solvent is removed with rotary evaporation.
In a second example, an isocyanate-terminated thiourethane oligomer can be produced when an excess of isocyanate compound is added to a thiol compound. For example, 5g of one or more isocyanate compounds can be added to 2 g of one or more thiol compounds in a two neck round bottom flask at room temperature. A mid-IR spectrum can be taken at this point. The flask is purged with N2 gas for one hour. A catalytic amount of triethyl amine is added. The flask is again purged with N2 gas for 10 minutes and immersed in an ice bath for four hours. A second mid-IR spectrum can be taken at this point. The thiol peak can be reduced (potentially to zero) if the reaction is complete. The resulting mixture is added drop wise to a volume of hexane that is 4x the volume of the mixture. This is allowed to separate at least 4 hours. The supernatant is discarded and the product is resuspended in dry acetone. Solvent is removed with rotary evaporation.
Dental composites comprising the disclosed compounds are also contemplated. Such dental composites can comprise the methacrylate/thiourethane oligomer compositions described. Such dental composites can further comprise tertiary amine, d-camphorquinone, inhibitors, and other compositions, including one or more filler compositions In such composites, a thiourethane oligomer can comprise at least 10% of the total weight of the dental composite.
EXAMPLES
Example 1 - Screening of methacrylamide monomers
Materials were made polymerizable by the addition of camphorquinone (0.5% by weight), ethyl-4-ethylaminoethyl benzoate (0.8% by weight) and 2-phenyliodonium
hexafluorophosphate (0.5% by weight). Materials (n=3) were exposed for 10 min at 800 mW/cm2 using a mercury arc lamp filtered to 320-500 nm.
The degree of vinyl conversion was followed in mid-infrared using the fundamental band at 3095 cm"1. This band was used instead of the more common 1640 cm"1 due to peak overlap and baseline issues. The band at 1720 cm 1 corresponding to the carbonyl bond was used as an internal reference. The results for this test are shown in Figure 4. All materials reached conversion values greater than 50%, with some examples reaching conversion as high as 85%. The rates of polymerization, however, are significantly lower than the methacrylate control (by 2-3 fold).
The methacrylate monomers were were produced in small quantities, not enough to produce the required amount of flexure bars. Therefore, shear modulus was measured using a DHR-1 rheometer (TA Instruments) using a 20 μιη gap, at a frequency of 1 Hz and strain of 0.1 %. The rheometer is equipped with a UV-accessory that allows for light access and in situ curing. The light intensity actually reaching the specimen was the same as used for the IR experiments. Total exposure time was 30 min, with data being collected every 1 s. Results for shear modulus at 10 and 30 min are shown in Figure 5.
Polyethylene glycol dimethacrylate (PEGDMA) was used as the control because its mechanical properties allowed the shear modulus of all materials to be collected using the same parameters on the rheometer. Storage shear modulus (G') was lower for all
methacrylamides compared to a dimethacrylate control (PEGDMA) at 10 min. At 30 min, some methacrylamides presented similar or greater G' than the control, adding evidence for the slower polymerization rate and network formation of the current systems.
Example 2 - Additional Compounds Synthesized
Figure imgf000011_0001
Figure imgf000012_0001
Figure imgf000012_0002
Figure imgf000012_0003
Figure imgf000012_0004
6DHMDI
Figure imgf000013_0001
6DHMDI
Figure imgf000013_0002
Figure imgf000013_0003
Figure imgf000013_0004
Figure imgf000014_0001


Claims

1. A compound with the structure:
Figure imgf000015_0001
wherein X is a 5- or 6-membered heterocycloalkyi, wherein n is an integer selected from 0, 1, and 2, and wherein R is selected from alkyi, substituted alkyi, aryl, substituted aryl, or dicycloalkyl.
2. The compound of claim 1 wherein X is a 5 membered ring and n=0.
3. The compound of claim 2 wherein R is selected from:
Figure imgf000015_0002
4. The compound of claim 1 wherein X is a 6 membered ring.
5. The compound of claim 4 wherein n=0.
6. The compound of claim 5 wherein R is selected from
Figure imgf000015_0003
and
6. The compound of claim 4 wherein n=l
7. The compound of claim 6 wherein R is selected from
Figure imgf000016_0001
8. The compound of claim 4 wherein n=2
9. The compound of claim 8 wherein R is selected from
Figure imgf000016_0002
10. A composition comprising:
the compound of any of claims 1-9 and a thiourethane oligomer.
11. The composition of claim 10 wherein the thiourethane oligomer comprises pendant thiols.
12. The composition of claim 10 wherein the thiourethane oligomer comprises pendant isocyanates. A dental composite comprising the composition of claims 10-12.
PCT/US2016/032481 2015-05-13 2016-05-13 Methacrylamide compounds Ceased WO2016183491A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562161043P 2015-05-13 2015-05-13
US62/161,043 2015-05-13

Publications (1)

Publication Number Publication Date
WO2016183491A1 true WO2016183491A1 (en) 2016-11-17

Family

ID=57249576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/032481 Ceased WO2016183491A1 (en) 2015-05-13 2016-05-13 Methacrylamide compounds

Country Status (2)

Country Link
US (1) US10342745B2 (en)
WO (1) WO2016183491A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055124A1 (en) * 2001-08-10 2003-03-20 Klee Joachim E. Hydrolysis stable one-part self-etching, self-priming dental adhesive
US20100041790A1 (en) * 2004-12-22 2010-02-18 Ivoclar Vivadent Ag Self-etching dental materials based on (meth)acrylamide phosphates
US20100249276A1 (en) * 2007-04-09 2010-09-30 Designer Molecules, Inc. Curatives for epoxy compositions
US20130199724A1 (en) * 2009-10-09 2013-08-08 Designer Molecules, Inc. Curatives for epoxy compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055124A1 (en) * 2001-08-10 2003-03-20 Klee Joachim E. Hydrolysis stable one-part self-etching, self-priming dental adhesive
US20100041790A1 (en) * 2004-12-22 2010-02-18 Ivoclar Vivadent Ag Self-etching dental materials based on (meth)acrylamide phosphates
US20100249276A1 (en) * 2007-04-09 2010-09-30 Designer Molecules, Inc. Curatives for epoxy compositions
US20130199724A1 (en) * 2009-10-09 2013-08-08 Designer Molecules, Inc. Curatives for epoxy compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KLEE, JOACHIM E. ET AL.: "N-alkyl-N-(phosphonoethyl) substituted (meth)acrylamides - new adhesive monomers for self-etching self-priming one part dental adhesive", BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, vol. 5, no. 72, 2 December 2009 (2009-12-02), pages 1 - 9, XP008134689 *

Also Published As

Publication number Publication date
US10342745B2 (en) 2019-07-09
US20160331647A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
JP2555365B2 (en) Acrylic acid derivative or methacrylic acid derivative of tricyclo [5.2.1.0 ▲ above 2 ▼ ・ ▲ above 6 ▼] decane
US4952241A (en) (Meth)acylic acid derivatives containing urethane groups
US9877898B2 (en) Dental materials based on low-odour thiols
JPH08245512A (en) Polymer of acrylic ester or methacrylic ester
US20100307378A1 (en) Carbamate-methacrylate monomers and their use in dental applications
KR101164302B1 (en) Phosphate ester compound, metal salt thereof, dental material, and dental composition
JP2004131468A (en) Dental material based on acrylic acid ester phosphonic acid
JP2013010763A (en) Low shrinkage and low stress dental composition
EP0804919A2 (en) Use of a composition as dental material and dental material
JP5216343B2 (en) Polymerizable monomer suitable for dental materials
JP2000204069A (en) Polymerizably unsaturated bond-containing n-substituted amide compound
US5070165A (en) Urea-containing (meth)acrylic acid derivatives of triisocyanates-compositions for an artificial tooth
US5886212A (en) Multifunctional vinyl cyclopropane derivatives
US8921450B2 (en) Dental materials based on dimer acid derivatives with ring opening polymerizable groups
JP5143580B2 (en) Dental composition and composite resin using the same
US10342745B2 (en) Methacrylamide compounds
JP7094165B2 (en) Polymeric material containing silane-based mobile reagents
US11793732B2 (en) Dental materials based on cyclopolymerizable crosslinkers
US11712404B2 (en) Methacrylamide adhesive systems
CA1295622C (en) (meth)-acrylic acid derivatives of triisocyanates in dentistry
WO2019189579A1 (en) Polymerizable composition for dental material, and dental material obtained from said composition
JP2012062280A (en) Bisacylphosphine oxide compound and polymerizable composition containing the same
US4870202A (en) (Meth)-acrylic acid derivatives of triisocyanates and their use
US5132335A (en) Acrylic and methacrylic esters of substituted 1,2-bis(phenoxy)-3,3,4,4,5,5-hexafluoro-1-cyclopentenes
US20240076304A1 (en) Monomer composition production method and monomer composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16793635

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16793635

Country of ref document: EP

Kind code of ref document: A1